RLX Technology Shares Jump 8.2% After FDA Authorizes Three Products

RLX Technology (RLX) shares rose in pre-market trading on October 16, 2026, after the company announced FDA authorization for three new products. The shares were up 8.2% on heavy volume.

Trading volume reached 1.2 million shares. The average daily volume is 870,000 shares, and the increase suggests strong institutional interest following the authorization.

FDA authorization is a key step toward marketing and selling the products in the United States, a major global market.